Nordion Inc. (USA) (NYSE:NDZ) had its target price trimmed by Canaccord Genuity from $12.75 to $11.75 in a report issued on Monday, Analyst Ratings Network reports. Nordion Inc. (USA) (NYSE:NDZ) shares after opening at $11.55 moved to $11.56 on last trade day and at the end of the day closed at $11.54. Company price to sales ratio in past twelve months was calculated as 2.87 and price to cash ratio as 2.24. Nordion Inc. (USA) (NYSE:NDZ) showed a positive weekly performance of 10.22%.
Albany Molecular Research (NASDAQ:AMRI) was upgraded by equities research analysts at The Street from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Analyst Ratings.Net reports. Albany Molecular Research, Inc. (NASDAQ:AMRI) shares fell -0.54% in last trading session and ended the day on $18.49. AMRI return on equity ratio is recorded as 5.70% and its return on assets is 4.00%. Albany Molecular Research, Inc. (NASDAQ:AMRI) yearly performance is 77.62%.
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) were disappointed when the Supreme Court decided to hear an appeal by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The decision will mean that Momenta will have to delay the launch of their own generic version of Copaxone. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares moved down -0.09% in last trading session and was closed at $11.64, while trading in range of $11.31 – $11.93. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) year to date (YTD) performance is -34.16%.
Spherix Inc. (NASDAQ:SPEX) has since lost some ground on the stock market, largely due to a dud volume-based transactions at the end of trading session. Spherix Inc. (NASDAQ:SPEX) weekly performance is -35.41%. On last trading day company shares ended up $3.01. Spherix Inc. (NASDAQ:SPEX) distance from 50-day simple moving average (SMA50) is -41.99%. Analysts mean target price for the company is $1.00.